Browse by Section 100 Item List
Highly Specialised Drugs Program (Private Hospital)
For Pharmaceutical Benefits Scheme (PBS) Highly Specialised Drugs prescribed through private hospitals, claiming and approval of authority prescriptions is administered by Services Australia. Highly Specialised Drugs prescribed in private hospitals are Authority Required items. Application for authorisation can be made by either:
- posting an Authority Prescription form and other application form(s), where applicable to Services Australia
- using the form upload facility in Health Professional Online Services (HPOS)
- using the Online PBS Authorities system (see www.servicesaustralia.gov.au/HPOS)
- using the Services Australia free-call service for PBS Complex Drugs Programs enquiries (1800 700 270) or
- using the appropriate Streamlined code.
Prescribers must quote the provider number of the hospital when applying. Maximum quantities and repeats for Highly Specialised Drugs are listed in the PBS Schedule. Authority approvals are required for prescriptions where the dose is above the determined maximum quantity and/or number of repeats.
Private hospital prescriptions for Highly Specialised Drugs can be dispensed by an approved private hospital dispensary or by a community pharmacy. A patient will be required to pay a contribution for each supply of a highly specialised drug at the same rate as the PBS.
The remuneration rates for Highly Specialised Drugs prescribed through private hospitals comprise the normal PBS ready-prepared dispensing fee plus a mark-up ascertained as follows:
- 10% for drugs with an ex-manufacturer price of less than $40
- $4 for drugs with an ex-manufacturer price of between $40 and $100
- 4% for drugs with an ex-manufacturer price of between $100.01 and $1000
- $40 for drugs with an ex-manufacturer price of greater than $1000.
Reciprocal Health Care Agreement – Where a patient is entitled to be treated as an eligible person as a visitor from a country with which Australia has entered into a Reciprocal Health Care Agreement, the supply will be limited to the original prescription only. Repeat prescriptions for these patients are not permitted.
- Legend
- MPMedical Practitioner
Prescriber code | Item code | Name, manner of administration and form & strength | Max qty packs |
Max qty units |
No. of repeats |
---|---|---|---|---|---|
MP | 10182X | ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial | 1 | 1 | 0 |
MP | 10192K | ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial | 1 | 1 | 4 |
MP | 10194M | ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial | 1 | 1 | 5 |
MP | 12864C | ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial | 1 | 1 | 0 |
MP | 12896R | ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial | 8 | 8 | 0 |
MP | 12899X | ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial | 6 | 6 | 5 |
MP | 14280N | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTORelexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg granules [28] (&) ivacaftor 75 mg granules [28], 56 | 1 | 1 | 5 |
MP | 14279M | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTORelexacaftor 80 mg + tezacaftor 40 mg + ivacaftor 60 mg granules [28] (&) ivacaftor 59.5 mg granules [28], 56 | 1 | 1 | 5 |
MP | 13266F | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTORelexacaftor 50 mg + tezacaftor 25 mg + ivacaftor 37.5 mg tablet [56] (&) ivacaftor 75 mg tablet [28], 84 | 1 | 1 | 5 |
MP | 12938Y | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTORelexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg tablet [56] (&) ivacaftor 150 mg tablet [28], 84 | 1 | 1 | 5 |
MP | 14115X | ELTROMBOPAGeltrombopag 25 mg tablet, 28 | 3 | 84 | 3 |
MP | 14119D | ELTROMBOPAGeltrombopag 25 mg tablet, 28 | 3 | 84 | 5 |
MP | 14136B | ELTROMBOPAGeltrombopag 25 mg tablet, 28 | 3 | 84 | 5 |
MP | 5827Q | ELTROMBOPAGeltrombopag 25 mg tablet, 28 | 1 | 28 | 5 |
MP | 14107L | ELTROMBOPAGeltrombopag 50 mg tablet, 28 | 3 | 84 | 3 |
MP | 14127M | ELTROMBOPAGeltrombopag 50 mg tablet, 28 | 3 | 84 | 5 |
MP | 14143J | ELTROMBOPAGeltrombopag 50 mg tablet, 28 | 3 | 84 | 5 |
MP | 5828R | ELTROMBOPAGeltrombopag 50 mg tablet, 28 | 1 | 28 | 5 |
MP | 6251B | EPOETIN ALFAepoetin alfa 1000 units/0.5 mL injection, 6 x 0.5 mL syringes | 2 | 12 | 5 |
MP | 6207Q | EPOETIN ALFAepoetin alfa 10 000 units/mL injection, 6 x 1 mL syringes | 2 | 12 | 5 |
MP | 6204M | EPOETIN ALFAepoetin alfa 2000 units/0.5 mL injection, 6 x 0.5 mL syringes | 2 | 12 | 5 |
MP | 6434P | EPOETIN ALFAepoetin alfa 20 000 units/0.5 mL injection, 6 x 0.5 mL syringes | 2 | 12 | 5 |
MP | 6205N | EPOETIN ALFAepoetin alfa 3000 units/0.3 mL injection, 6 x 0.3 mL syringes | 2 | 12 | 5 |
MP | 6206P | EPOETIN ALFAepoetin alfa 4000 units/0.4 mL injection, 6 x 0.4 mL syringes | 2 | 12 | 5 |
MP | 6339P | EPOETIN ALFAepoetin alfa 40 000 units/mL injection, 1 mL syringe | 2 | 2 | 5 |
MP | 6302Q | EPOETIN ALFAepoetin alfa 5000 units/0.5 mL injection, 6 x 0.5 mL syringes | 2 | 12 | 5 |
MP | 6303R | EPOETIN ALFAepoetin alfa 6000 units/0.6 mL injection, 6 x 0.6 mL syringes | 2 | 12 | 5 |
MP | 6305W | EPOETIN ALFAepoetin alfa 8000 units/0.8 mL injection, 6 x 0.8 mL syringes | 2 | 12 | 5 |
MP | 6485H | EPOETIN BETAepoetin beta 10 000 units/0.6 mL injection, 6 x 0.6 mL syringes | 2 | 12 | 5 |
MP | 6480C | EPOETIN BETAepoetin beta 2000 units/0.3 mL injection, 6 x 0.3 mL syringes | 2 | 12 | 5 |
MP | 6481D | EPOETIN BETAepoetin beta 3000 units/0.3 mL injection, 6 x 0.3 mL syringes | 2 | 12 | 5 |
MP | 6482E | EPOETIN BETAepoetin beta 4000 units/0.3 mL injection, 6 x 0.3 mL syringes | 2 | 12 | 5 |
MP | 6483F | EPOETIN BETAepoetin beta 5000 units/0.3 mL injection, 6 x 0.3 mL syringes | 2 | 12 | 5 |
MP | 6484G | EPOETIN BETAepoetin beta 6000 units/0.3 mL injection, 6 x 0.3 mL syringes | 2 | 12 | 5 |
MP | 9685R | EPOETIN LAMBDAepoetin lambda 1000 units/0.5 mL injection, 6 x 0.5 mL syringes | 2 | 12 | 5 |
MP | 9595B | EPOETIN LAMBDAepoetin lambda 10 000 units/mL injection, 6 x 1 mL syringes | 2 | 12 | 5 |
MP | 9686T | EPOETIN LAMBDAepoetin lambda 2000 units/mL injection, 6 x 1 mL syringes | 2 | 12 | 5 |
MP | 9687W | EPOETIN LAMBDAepoetin lambda 3000 units/0.3 mL injection, 6 x 0.3 mL syringes | 2 | 12 | 5 |
MP | 9688X | EPOETIN LAMBDAepoetin lambda 4000 units/0.4 mL injection, 6 x 0.4 mL syringes | 2 | 12 | 5 |
MP | 9588P | EPOETIN LAMBDAepoetin lambda 5000 units/0.5 mL injection, 6 x 0.5 mL syringes | 2 | 12 | 5 |
MP | 9590R | EPOETIN LAMBDAepoetin lambda 6000 units/0.6 mL injection, 6 x 0.6 mL syringes | 2 | 12 | 5 |
MP | 9593X | EPOETIN LAMBDAepoetin lambda 8000 units/0.8 mL injection, 6 x 0.8 mL syringes | 2 | 12 | 5 |
MP | 11082G | EPOPROSTENOLepoprostenol 1.5 mg injection [1 vial] (&) inert substance diluent [2 x 50 mL vials], 1 pack | 30 | 30 | 5 |
MP | 11069N | EPOPROSTENOLepoprostenol 500 microgram injection [1 vial] (&) inert substance diluent [2 x 50 mL vials], 1 pack | 30 | 30 | 5 |
MP | 10129D | EPOPROSTENOLepoprostenol 1.5 mg injection, 1 vial | 30 | 30 | 5 |
MP | 10111E | EPOPROSTENOLepoprostenol 500 microgram injection, 1 vial | 30 | 30 | 5 |
MP | 13326J | ETANERCEPTetanercept 50 mg/mL injection, 4 x 1 mL pen devices | 1 | 1 | 5 |
MP | 9641K | ETANERCEPTetanercept 50 mg/mL injection, 4 x 1 mL pen devices | 1 | 1 | 0 |
MP | 13295R | ETANERCEPTetanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack | 2 | 2 | 5 |
MP | 6367D | ETANERCEPTetanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack | 1 | 1 | 0 |
MP | 13332Q | ETANERCEPTetanercept 50 mg/mL injection, 4 x 1 mL syringes | 1 | 1 | 5 |
MP | 9615C | ETANERCEPTetanercept 50 mg/mL injection, 4 x 1 mL syringes | 1 | 1 | 0 |
MP | 6460B | EVEROLIMUSeverolimus 500 microgram tablet, 60 | 2 | 120 | 5 |
MP | 6461C | EVEROLIMUSeverolimus 750 microgram tablet, 60 | 4 | 240 | 5 |
MP | 9582H | EVEROLIMUSeverolimus 1 mg tablet, 60 | 4 | 240 | 5 |
MP | 6459Y | EVEROLIMUSeverolimus 250 microgram tablet, 60 | 2 | 120 | 5 |